{"id":12740,"date":"2022-03-01T16:16:14","date_gmt":"2022-03-01T15:16:14","guid":{"rendered":"https:\/\/iabnetz.de\/?post_type=publikationen&p=12740"},"modified":"2025-11-14T22:32:58","modified_gmt":"2025-11-14T21:32:58","slug":"modified-constraint-induced-movement-therapy-or-bimanual-occupational-therapy-following-injection-of-botulinum-toxin-a-to-improve-bimanual-performance-in-young-children-with-hemiplegic-cerebral-pa-15","status":"publish","type":"page","link":"https:\/\/relaunch.iabnetz.com\/en\/publikationen\/weitere-veroeffentlichungen\/modified-constraint-induced-movement-therapy-or-bimanual-occupational-therapy-following-injection-of-botulinum-toxin-a-to-improve-bimanual-performance-in-young-children-with-hemiplegic-cerebral-pa-15\/","title":{"rendered":"Field effect of two commercial preparations of botulinum toxin type A: A prospective, double-blind, randomized clinical trial: Hexsel D et al."},"content":{"rendered":"

<\/p>\n

\n
\n
<\/div>\n
\n
\n
\n
\n
\n
2011 by the American Academy of Dermatology, Inc.
\n<\/span>doi<\/span>:<\/a><\/span>10.1016\/j.jaad.2011.08.011<\/a><\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
Authors:<\/span><\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
Doris Hexsel, MD,\u00a0 \u00a0<\/span>a,b<\/span><\/div>\n
Cristiano Brum, MD,\u00a0 \u00a0<\/span>a,e<\/span><\/div>\n
De<\/span>\u00b4<\/span>bora Zechmeister do Prado, BPharm,\u00a0 \u00a0<\/span>a<\/span><\/div>\n
Mariana Soirefmann, MD, MSc,\u00a0 \u00a0<\/span>a,b<\/span><\/div>\n
Francisco Telechea Rotta, MD,\u00a0 \u00a0 d<\/span><\/div>\n
Taciana Dal\u2019Forno, MD, PhD,\u00a0 \u00a0<\/span>a,b<\/span><\/div>\n
and Ticiana C. Rodrigues, MD, PhD\u00a0 \u00a0<\/span>a,c<\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\u00a0<\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\u00a0<\/a><\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

 <\/p>\n

\n

Author Details:<\/p>\n

\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
From the Brazilian Center for Studies in Dermatology,\u00a0 \u00a0<\/span>a<\/span><\/div>\n
Pontificia<\/span>UniversidadeCatolicadoRioGrandedoSul,\u00a0 \u00a0<\/span><\/span><\/span>b<\/span><\/div>\n
EndocrineDivision,<\/span><\/span>Hospital de Cl<\/span><\/span><\/span>\u0131nicas\u00a0of\u00a0Porto\u00a0Alegre,\u00a0 \u00a0<\/span><\/span><\/span>c<\/span><\/div>\n
Moinhos\u00a0de\u00a0Vento<\/span><\/span>Hospital,\u00a0 \u00a0<\/span>d<\/span><\/div>\n
and Complexo Hospitalar Santa Casa.\u00a0 \u00a0<\/span>e<\/span><\/div>\n
Supported by the Brazilian Center for Studies in Dermatology, a<\/span>nonprofit organization that received an educational grant from<\/span>Ipsen (the manufacturer of Dysport).<\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n

Please click here!<\/a><\/p>\n<\/div>\n<\/div>\n

<\/p>","protected":false},"excerpt":{"rendered":"

Background: The dose equivalence of commonly used commercial preparations of botulinum toxin type A, Dysport (abotulinumtoxinA [ABO] 500 U, Ipsen Biopharm Limited, Wrexham, United Kingdom) and Botox (onabotulinumtoxinA [ONA] 100 U, Allergan, Irvine, CA), remains unclear. …<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":30426,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-full-width.php","meta":{"_acf_changed":false,"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"class_list":["post-12740","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/12740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/comments?post=12740"}],"version-history":[{"count":1,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/12740\/revisions"}],"predecessor-version":[{"id":30670,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/12740\/revisions\/30670"}],"up":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/30426"}],"wp:attachment":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/media?parent=12740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}